Navigation Links
Blood-Thinner Plavix Works Harder in Smokers
Date:8/4/2008

But the finding certainly isn't any reason to start or continue smoking, researchers say

MONDAY, Aug. 4 (HealthDay News) -- The widely used anti-clotting drug Plavix appears to have a stronger effect in people who smoke, a study indicates.

Plavix (clopidogrel) is often given to heart attack patients after the attack. It inhibits formation of clots by blood cells called platelets.

The study of 259 people given Plavix because of coronary conditions found that those who smoked had significantly less clot formation than nonsmokers.

But it's still too early to say that doctors should include smoking among the factors that affect whether Plavix should be prescribed or how large the dose should be, said study lead author Dr. Paul A. Gurbel, associate professor of medicine at Johns Hopkins University and director of the Sinai Center for Thrombosis Research, Baltimore.

"I don't know if we can jump to that conclusion yet," Gurbel said. "We need to study this further. We do know from two large-scale clinical trials that smokers benefited more when they got Plavix therapy. Maybe smoking does something to make Plavix work better."

That "something" probably occurs in the liver, where the drug is metabolized, Gurbel said. Cigarette smoking increases the production of CYP1A2, a liver enzyme that converts the drug to its active form, he said.

"Current smoking was an independent predictor of low platelet aggregation," the journal report said.

Of course, lower clotting action can sometimes mean a higher risk for bleeding. But Gurbel said that, based on these early findings, "we don't know if [smoking patients] will bleed more."

The findings were expected to be published in the Aug. 12 issue of the Journal of the American College of Cardiology.

Plavix is widely used to prevent coronary problems and is commonly prescribed after a heart attack. A standard recommendation for heart attack patients includes a year of combined therapy with Plavix and aspirin, another clot-preventing drug.

The indication that smoking reduces platelet stickiness in people given Plavix "is certainly observational at this point" and requires proof in a large, controlled trial, Gurbel said.

"Were trying to get funding for a trial right now," he said.

The trial he envisions would enroll a large group of smokers who would all be prescribed Plavix. "Then we would remove the smoking in half the group," Gurbel said. "We would see whether that removal adds support for our observation."

The hardest part of such a trial would be to get half a group of smokers to quit, Gurbel acknowledged.

"And were definitely not telling people to smoke if they have heart disease," he said. Smoking is high on the list of risk factors for heart attack, stroke and other cardiovascular problems, Gurbel noted.

The study was funded in part by a grant from drug maker Daiichi Sankyo Inc.

More information

For move on Plavix, head to the U.S. National Library of Medicine.



SOURCES: Paul A. Gurbel, M.D., director, Sinai Center for Thrombosis Research, Baltimore; Aug. 12, 2008, Journal of the American College of Cardiology


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Blood-Thinner No Help for Dialysis Treatment
2. Blood-Thinner Contaminant Traced to Chinese Plant
3. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
4. First 90 Days After Stopping Plavix Most Dangerous
5. Once-Daily Combo Works for New HIV Patients
6. Plexus Consulting Group Works With a USAID-Funded Project to Help the Private Hospitals Association of Jordan Create a Roadmap for the Future
7. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
8. DIA And FDA To Host Two Important Critical Path Workshops
9. Autisms social struggles due to disrupted communication networks in brain
10. Ceridian LifeWorks Offers CareGiverHelper Service to Clients to Ease Stress of Family Caregiving
11. Workshop Helps Parents, Kids Talk About Sex
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood-Thinner Plavix Works Harder in Smokers
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... provider of comprehensive treatment for eating disorders, is opening a brand new child ... provide individuals ages 8-17 and their families with even more specialized eating disorder ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian ... Regeneration. The conference was held during May 5-6, 2016 in Chicago, IL, USA. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie , the manufacturer of the ... more than humbled by customer demand over the Mother’s Day Weekend promotion. So much ... that Bunion Bootie has completely replenished its inventory levels, it hopes to continue its ...
(Date:5/26/2016)... ... 26, 2016 , ... The introduction of our professional athletes coincides with the ... , “We are proud to introduce Meghan Klingenberg, defender and World Champion ... Quick, wide receiver for Los Angeles who was a second round selection in the ...
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips ... central to popular cosmetic improvement efforts. Record numbers of clients now ask about lip ... or pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: